Pricing Log in Create free account

BeyondSpring Inc. (BYSI) vs Estrella Immunopharma, Inc. (ESLA)

BeyondSpring Inc. and Estrella Immunopharma, Inc. are both Biotechnology companies. BeyondSpring Inc. and Estrella Immunopharma, Inc. are of similar size ($23.9M and $23.3M). Across the 7 metrics below, BeyondSpring Inc. leads on 4 and Estrella Immunopharma, Inc. on 3.

Valuation

Metric BYSI ESLA Biotechnology median
P/E n/m n/m 8.50
P/S 17.04 n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 13.84 n/m 9.21
Earnings yield (46.95%) (56.72%) (33.15%)
Free cash flow yield (72.94%) (50.75%) (25.50%)

Profitability

Metric BYSI ESLA Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 24.96% 148.05% (56.36%)
Return on assets (29.29%) (416.74%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BYSI ESLA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 96.30% (188.78%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BYSI ESLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.70 0.20 4.72
Net debt to EBITDA 1.42 0.11 0.96

Dividend

Metric BYSI ESLA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BYSI ESLA Biotechnology median
Market cap 23.93m 23.28m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack